Researchers tracked 8,914 insured patients in JAMA Health Forum. Above $75 out of pocket, nonadherence topped 80%, says author Eunhae Shin.
Recap by typeshit. Full story at Georgia Public Broadcasting.
Ireland's drug pricing body recommended semaglutide over tirzepatide for cost reasons, and Higgins says it's the right call, with a pun he didn't get to use.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
Researchers from Taif and Umm Al-Qura universities say limiting coverage to patients with a related condition would cut the public bill to SAR 10.96 billion.
Avi Roy puts last year's sales of the two shots at $71B, roughly four times the $18B he says the two AI labs brought in.
The obesity specialist says the drugs act on inflammation directly, not just through weight loss, and that benefits fade when patients stop taking them.
PwC Middle East's Voice of the Consumer 2025 survey covered Saudi Arabia, the UAE, Qatar and more, with 9% of respondents tied to GLP-1s.
Loading…